» Articles » PMID: 28179169

Vertebral Bone Marrow Fat, Bone Mineral Density and Diabetes: The Osteoporotic Fractures in Men (MrOS) Study

Overview
Journal Bone
Date 2017 Feb 10
PMID 28179169
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated vertebral bone marrow fat (BMF) among individuals with osteoporosis has been established in histomorphometric studies. Several studies have found a negative correlation between BMF and bone mineral density (BMD) at the spine in men and women across different age groups. Animal studies have also observed bone loss with increased BMF in mice with induced diabetes. Our study objective was to test the hypothesis that the association between BMF and BMD varies by diabetic status. We performed a cross-sectional study of 156 men aged 74-96years from the Osteoporotic Fractures in Men study at the Pittsburgh clinical site. All men had spine BMF scans using proton magnetic resonance spectroscopy and spine and hip BMD scans by dual-energy X-ray absorptiometry. BMF was expressed as lipid to "lipid+water" ratio (%). Men were considered diabetic if they self-reported a physician diagnosis of diabetes, diabetes medication or had a fasting glucose ≥126mg/dl. Men with diabetes (n=38) had a significantly higher spine BMF (58.9 vs. 54.6%, p=0.0035), spine BMD (1.20 vs. 1.10g/cm, P=0.007) and total hip BMD (1.00 vs. 0.94g/cm, p=0.04) than those without, while no differences were observed for body weight, body mass index or waist circumference. Pearson correlation tests showed no significant correlation of spine BMF with age or BMD in non-diabetics. Significant inverse correlations were observed between BMF and BMD (-0.30 for femoral neck and -0.39 for total hip) among diabetic men. In conclusion, men with diabetes had a higher BMF compared to non-diabetic men. The correlation between BMF and BMD differed by diabetes status. Further investigation of the association of diabetes with BMF and BMD may provide a better understanding of the high fracture rates among individuals with diabetes despite their higher BMD.

Citing Articles

The Never Ending Story-What Are the Differentiable Magnetic Resonance Imaging Characteristics Between Pyogenic and Mycobacterial Thoracolumbar Infections?.

Wasko M, Bialecki J, Nowak O, Kwiatkowska-Miernik A, Bujko-Malkiewicz A, Walecki J J Clin Med. 2025; 14(2).

PMID: 39860322 PMC: 11766180. DOI: 10.3390/jcm14020318.


Bone Marrow Adipocytes as Novel Regulators of Metabolic Homeostasis: Clinical Consequences of Bone Marrow Adiposity.

Liu H, Liu L, Rosen C Curr Obes Rep. 2025; 14(1):9.

PMID: 39808256 DOI: 10.1007/s13679-024-00594-9.


Orphan nuclear receptor NR4A1 regulates both osteoblastogenesis and adipogenesis in human mesenchymal stem cells.

Jin Y, Son Y, Song I, Chung Y, Choi Y Mol Med Rep. 2024; 31(1).

PMID: 39422036 PMC: 11544528. DOI: 10.3892/mmr.2024.13368.


Adiposity and Mineral Balance in Chronic Kidney Disease.

Hosain O, Clinkenbeard E Curr Osteoporos Rep. 2024; 22(6):561-575.

PMID: 39394545 DOI: 10.1007/s11914-024-00884-0.


Bone Marrow Adiposity Alterations in Postmenopausal Women With Type 2 Diabetes Are Site-Specific.

Badr S, Cotten A, Lombardo D, Ruschke S, Karampinos D, Ramdane N J Endocr Soc. 2024; 8(11):bvae161.

PMID: 39381685 PMC: 11458911. DOI: 10.1210/jendso/bvae161.


References
1.
Slade J, Coe L, Meyer R, McCabe L . Human bone marrow adiposity is linked with serum lipid levels not T1-diabetes. J Diabetes Complications. 2012; 26(1):1-9. DOI: 10.1016/j.jdiacomp.2011.11.001. View

2.
Weiss L, Barrett-Connor E, von Muhlen D, Clark P . Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study. J Bone Miner Res. 2006; 21(5):758-64. DOI: 10.1359/jbmr.060206. View

3.
Schafer A, Li X, Schwartz A, Tufts L, Wheeler A, Grunfeld C . Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study. Bone. 2015; 74:140-5. PMC: 4355193. DOI: 10.1016/j.bone.2015.01.010. View

4.
Patsch J, Li X, Baum T, Yap S, Karampinos D, Schwartz A . Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res. 2013; 28(8):1721-8. PMC: 3720702. DOI: 10.1002/jbmr.1950. View

5.
Botolin S, Faugere M, Malluche H, Orth M, Meyer R, McCabe L . Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology. 2005; 146(8):3622-31. PMC: 1242186. DOI: 10.1210/en.2004-1677. View